Hepatitis is an inflammation of the liver mainly induced by autoimmunity, chemical, or infectious agents. In the United States, the third most prevalent form of chronic infectious hepatitis is caused by hepatitis C virus (HCV). Worldwide there are an estimated 170 million people infected with HCV with nearly 4 million infected individuals in the United States.
>> Learn more
Virobay is an anti-viral drug discovery and development company, creating the next generation of treatments for hepatitis C. We are adopting an innovative approach to drug discovery and development, using validated clinical targets in therapeutic areas poised for dramatic change.
 |
 |
 |
 |
 |
 |
| Protease inhibitors | |||||
| VBY 376 |  |
||||
| Next Generation |  |
||||
| Polymerase Inhibitors | |||||
| VBY 708 | |
||||
